SEC Form 4 · accession 0000899243-19-004732
AILERON THERAPEUTICS INC · ALRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathryn Gregory
Officer — SVP, Chief Business Officer
Period of report
Feb 25, 2019
Accepted (ET)
Feb 25, 2019 · 5:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420565
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.47 | Feb 25, 2019 | A | 100,000 | A | — | Feb 24, 2029 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1This option was granted on February 25, 2019. The shares underlying the option are scheduled to vest as to 25% of the shares on February 25, 2020 and thereafter in equal monthly installments through February 25, 2023.